Sven Meuth,Kerstin Goebel,Christoph Kleinschnitz,Brent McKenzie,Marc Nolte
申请号：
US14374300
公开号：
US09957329B2
申请日:
2013.01.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This application relates to neurological inflammatory diseases, such as multiple sclerosis, and to methods of administering a Factor XII inhibitor to prevent, treat, or otherwise ameliorate the effects of a neurological inflammatory disease, such as multiple sclerosis. Agents and pharmaceutical compositions comprising agents which inhibit the activity of FXII are also provided.
